Interferon induced thyroiditis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Interferon-alpha (IFNα) is used for the treatment of various disorders, most notable chronic hepatitis C virus (HCV) infection. One of the commonest side effects of IFNα therapy is thyroiditis, with up to 40% of HCV patients on IFNα developing clinical or subclinical disease. In some cases interferon induced thyroiditis (IIT) may result in severe symptomatology necessitating discontinuation of therapy. IIT can manifest as clinical autoimmune thyroiditis, presenting with symptoms of classical Hashimoto’s thyroiditis or Graves’ disease, or as non-autoimmune thyroiditis. Non-autoimmune thyroiditis can manifest as destructive thyroiditis, with early thyrotoxicosis and later hypothyroidism, or as non-autoimmune hypothyroidism. While the epidemiology and clinical presentation of IIT have been well characterized the mechanisms causing IIT are still poorly understood. It is likely that the hepatitis C virus (HCV) itself plays a role in the disease, as the association between HCV infection and thyroiditis is well established. It is believed that IFNα induces thyroiditis by both immune stimulatory effects and by direct effects on the thyroid. Early detection and therapy of this condition are important in order to avoid complications of thyroid disease such as cardiac arrhythmias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · cited 1×
“The most common form of thyroid autoimmunity is the presence of thyroid antibodies [including thyroid peroxidase antibodies (TPO-Ab), and thyroglobulin antibodies (Tg-Ab)], without clinical disease (22).”
Interferon-α and Autoimmune Thyroid Disease
Prummel, M. F., & Laurberg, P. (2003) · Thyroid · doi:10.1089/105072503322238809 · Cited by 221
KOH, L. K. H., GREENSPAN, F. S., & YEO, P. P. B. (1997) · Thyroid · doi:10.1089/thy.1997.7.891 · Cited by 185
Cited by
Hashimotos' thyroiditis: epidemiology, pathogenesis, clinic and therapy
Ragusa, F., Fallahi, P., Elia, G., Gonnella, D., Paparo, S. R., Giusti, C., Churilov, L. P., Ferrari, S. M., & Antonelli, A. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101367 · Cited by 655
MECHANISMS IN ENDOCRINOLOGY: Autoimmune thyroid disease: old and new players
Effraimidis, G., & Wiersinga, W. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0047 · Cited by 350
Mild Hypothyroidism in Childhood: Who, When, and How Should Be Treated?
Vigone, M. C., Capalbo, D., Weber, G., & Salerno, M. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2017-00471 · Cited by 51
Mammen, J. S., Ghazarian, S. R., Pulkstenis, E., Subramanian, G. M., Rosen, A., & Ladenson, P. W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1026 · Cited by 16
Metadata
- Authors
- Tomer, Y., & Menconi, F.
- Venue
- Best Practice & Research Clinical Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 23
- Issue
- 6
- Pages
- 703-712
- ISSN
- 1521-690X (ISSN-L)
- OpenAlex
- W2068820269
- Cited by
- 122
- References
- 3
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon induced thyroiditis. https://app.cochat.ai/papers/10.1016/j.beem.2009.07.004
- The paper
- Tomer, Y., & Menconi, F. (2009). Interferon induced thyroiditis. Best Practice & Research Clinical Endocrinology & Metabolism. https://doi.org/10.1016/j.beem.2009.07.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.